Will NVIDIA Return to Its 52-Week High?
NVIDIA (NASDAQ:NVDA) has been among the best-performing investments of the…
Sell
38
SAGE Quote, Financials, Valuation and Earnings
Last price:
$7.14
Seasonality move
:
7.04%
Day range:
$6.77 - $7.20
52-week range:
$4.62 - $16.37
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
10.55x
P/B ratio:
0.95x
Volume:
1.1M
Avg. volume:
1.4M
1-year change:
-56.79%
Market cap:
$440.2M
Revenue:
$41.2M
EPS (TTM):
-$6.59
SAGE Analysts' Consensus Rating
The 15 analysts providing 12-month price projections for Sage Therapeutics shares anticipate an average target of $8.10, ranging from a low estimate of $5.00 to a high estimate of $12.00. This average target implies a growth of 13.15% compared to the current stock price of $7.16.
Consensus Price Target
$8.10
Highest Price Target
$12.00
Lowest Price Target
$5.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 0 | 0 | 0 |
| Hold | 16 | 15 | 15 |
| Sell | 0 | 0 | 0 |
| Consensus | Hold | Hold | Hold |
SAGE Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
